Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2): positive advanced breast cancer
Crossref DOI link: https://doi.org/10.1007/s10549-016-3958-x
Published Online: 2016-08-29
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Le, Quang A.
Bae, Yuna H.
Kang, Jenny H.
License valid from 2016-08-29